Physical properties of red cells as related to effects in vivo. IV. Oxidant drugs producing abnormal intracellular concentration of hemoglobin (eccentrocytes) with a rigid-red-cell hemolytic syndrome.
D000700:Analgesics; D000743:Anemia, Hemolytic / Q000097:blood / Q000139:chemically induced; D000818:Animals; D000890:Anti-Infective Agents; D002414:Cations, Monovalent; D002860:Chromium Radioisotopes; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology; D004913:Erythrocytes, Abnormal / Q000187:drug effects; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D005980:Glutathione Reductase / Q000097:blood; D006366:Heinz Bodies; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis / Q000378:metabolism; D006461:Hemolysis; D006801:Humans; D008855:Microscopy, Electron, Scanning; D010659:Phenylhydrazines / Q000494:pharmacology*; D010734:Phosphogluconate Dehydrogenase / Q000097:blood; D012156:Reticulocytes / Q000201:enzymology; D013154:Spleen / Q000473:pathology; D014867:Water / Q000032:analysis
D000700:Analgesics; D000890:Anti-Infective Agents; D002414:Cations, Monovalent; D002860:Chromium Radioisotopes; D006454:Hemoglobins; D010659:Phenylhydrazines; D014867:Water; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D005980:Glutathione Reductase